ABOS
Price
$1.07
Change
-$0.07 (-6.14%)
Updated
Jun 13 closing price
Capitalization
64.81M
64 days until earnings call
ACIU
Price
$1.95
Change
-$0.12 (-5.80%)
Updated
Jun 13 closing price
Capitalization
195.8M
52 days until earnings call
Interact to see
Advertisement

ABOS vs ACIU

Header iconABOS vs ACIU Comparison
Open Charts ABOS vs ACIUBanner chart's image
Acumen Pharmaceuticals
Price$1.07
Change-$0.07 (-6.14%)
Volume$199.31K
Capitalization64.81M
AC Immune SA
Price$1.95
Change-$0.12 (-5.80%)
Volume$134.24K
Capitalization195.8M
ABOS vs ACIU Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ACIU commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and ACIU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 16, 2025
Stock price -- (ABOS: $1.07 vs. ACIU: $1.95)
Brand notoriety: ABOS and ACIU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 94% vs. ACIU: 105%
Market capitalization -- ABOS: $64.81M vs. ACIU: $195.8M
ABOS [@Biotechnology] is valued at $64.81M. ACIU’s [@Biotechnology] market capitalization is $195.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $356.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileACIU’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ACIU’s FA Score: 0 green, 5 red.
According to our system of comparison, ACIU is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while ACIU’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 4 bearish.
  • ACIU’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ABOS and ACIU are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а -10.83% price change this week, while ACIU (@Biotechnology) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.63%. For the same industry, the average monthly price growth was +13.05%, and the average quarterly price growth was +4.06%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

ACIU is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($196M) has a higher market cap than ABOS($64.8M). ACIU YTD gains are higher at: -27.778 vs. ABOS (-37.791). ACIU has higher annual earnings (EBITDA): -49.71M vs. ABOS (-111.98M). ABOS (149M) and ACIU (146M) have equal amount of cash in the bank . ACIU has less debt than ABOS: ACIU (5.18M) vs ABOS (29M). ACIU has higher revenues than ABOS: ACIU (28.3M) vs ABOS (0).
ABOSACIUABOS / ACIU
Capitalization64.8M196M33%
EBITDA-111.98M-49.71M225%
Gain YTD-37.791-27.778136%
P/E RatioN/AN/A-
Revenue028.3M-
Total Cash149M146M102%
Total Debt29M5.18M560%
FUNDAMENTALS RATINGS
ACIU: Fundamental Ratings
ACIU
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
3

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSACIU
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend about 1 month ago
77%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPTX1.470.02
+1.17%
Repare Therapeutics
TARS40.89-0.06
-0.15%
Tarsus Pharmaceuticals
MSFT474.96-3.91
-0.82%
Microsoft Corp
AIT225.66-4.58
-1.99%
Applied Industrial Technologies
AURA6.42-0.25
-3.75%
Aura Biosciences

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-6.14%
FHTX - ABOS
52%
Loosely correlated
-4.85%
CRBU - ABOS
52%
Loosely correlated
-4.31%
BEAM - ABOS
50%
Loosely correlated
-2.18%
ATOS - ABOS
48%
Loosely correlated
-3.74%
CRSP - ABOS
48%
Loosely correlated
+0.19%
More

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with RGNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
-5.80%
RGNX - ACIU
43%
Loosely correlated
-9.12%
CRBU - ACIU
42%
Loosely correlated
-4.31%
ABOS - ACIU
41%
Loosely correlated
-6.14%
PRME - ACIU
39%
Loosely correlated
N/A
CRSP - ACIU
39%
Loosely correlated
+0.19%
More